Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 8,255 | 0 | 25 | 25 | 8,749 |
| Gross Profit | 8,255 | N/A | 25 | 25 | 8,749 |
| Operating Expenses | 30,064 | 16,576 | 10,663 | 12,199 | 8,532 |
| Operating Income | -21,809 | -16,576 | -10,638 | -12,174 | 216 |
| Interest Expense | 7 | 25 | 42 | 32 | 14 |
| Other Income | 719 | 290 | 213 | 469 | 540 |
| Pre-tax Income | -21,097 | -16,311 | -10,467 | -11,737 | 742 |
| Income Tax | N/A | N/A | N/A | -102 | 200 |
| Net Income Continuous | -21,097 | -16,311 | -10,467 | -11,636 | 542 |
| Net Income | $-21,097 | $-16,311 | $-10,467 | $-11,636 | $542 |
| EPS Basic Total Ops | -34,823.63 | -32,053.56 | -26,909.16 | -34,032.18 | 1,978.62 |
| EPS Basic Continuous Ops | -34,746.46 | -32,001.56 | -26,716.51 | -33,947.49 | 2,085.44 |
| EPS Diluted Total Ops | -34,823.63 | -32,053.56 | -26,909.16 | -34,032.18 | 1,978.62 |
| EPS Diluted Continuous Ops | -34,746.46 | -32,001.56 | -26,716.51 | -33,947.49 | 1,942.01 |
| EBITDA(a) | $-21,223 | $-16,060 | $-10,258 | $-11,594 | $472 |